Genovel Orthopedics, NYU Sign Agreement to Develop Knee Osteoarthritis Treatment Technology

 

Genovel Orthopedics has signed a research and license agreement with New York University for the development and commercialization of a new technology for osteoarthritis of the knee.

Advertisement

The technology — designed by Peter S. Walker, PhD, professor, department of orthopedic surgery, department of mechanical and aerospace engineering, NYU-Polytechnic; and Joseph Bosco, MD, associate professor, vice chair for clinical affairs, department of orthopedic surgery at NYU School of Medicine — is a next-generation treatment for patients who suffer from osteoarthritis of the knee.

 

Genovel Orthopedics is a company founded by Pansend, a wholly owned subsidiary of HC2 Holdings.

More Articles on Orthopedics:

University of Rochester Medical Center Receives 750k Gift for Orthopedic Research
Dr. James Andrews Performs Elbow Surgery on Pittsburgh Pirate Kyle McPherson
Dr. Tariq Hussain Joins UHS Orthopedics-Norwich

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.